[Change in health-related problems of cocaine consumption in Catalonia, Spain].

PubWeight™: 1.41‹?› | Rank: Top 5%

🔗 View Article (PMID 11714455)

Published in Med Clin (Barc) on November 10, 2001

Authors

J M Suelves1, M T Brugal, J A Caylà, L Torralba

Author Affiliations

1: Departamento de Sanidad y Seguridad Social, Generalitat de Catalunya.

Articles by these authors

Meningococcal disease in a large urban population (Barcelona, 1987-1992): predictors of dismal prognosis. Barcelona Meningococcal Disease Surveillance Group. Arch Intern Med (1999) 2.40

Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. Barcelona Meningococcal Disease Surveillance Group. JAMA (1997) 2.13

Tuberculosis control in big cities and urban risk groups in the European Union: a consensus statement. Euro Surveill (2014) 1.66

Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus? Int J Tuberc Lung Dis (2005) 1.60

[A contagiousness study in 3071 familial contacts of tuberculosis patients]. Med Clin (Barc) (1997) 1.54

Proposing indicators for evaluation of tuberculosis control programmes in large cities based on the experience of Barcelona. Int J Tuberc Lung Dis (2001) 1.53

[Drug resistance in Mycobacterium tuberculosis. A multicenter study of the Barcelona area. Grupo de Trabajo sobre Resistencias en Tuberculosis]. Med Clin (Barc) (2000) 1.48

[The epidemiology of the acute adverse drug reaction in Barcelona in 1983-1992: a mortality analysis]. Med Clin (Barc) (1995) 1.41

Readiness to change questionnaire: reliability study of its Spanish version. Alcohol Alcohol (2000) 1.40

Diagnostic efficacy of the study of contacts of tuberculosis patients in a high prevalence urban area. Rev Clin Esp (2000) 1.39

[The evolution of AIDS mortality and survival in Barcelona (1981-1997)]. Med Clin (Barc) (1999) 1.38

Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients. Int J Tuberc Lung Dis (2002) 1.29

Tuberculosis recurrence and its associated risk factors among successfully treated patients. J Epidemiol Community Health (2009) 1.23

Characteristics of tuberculosis patients who generate secondary cases. Int J Tuberc Lung Dis (1997) 1.19

Analytical considerations in the use of capture-recapture to estimate prevalence: case studies of the estimation of opiate use in the metropolitan area of Barcelona, Spain. Am J Epidemiol (1998) 1.17

Screening for tuberculosis upon admission to shelters and free-meal services. Eur J Epidemiol (2001) 1.12

Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release. Study Group of Adherence to Tuberculosis Treatment of Prisoners. Eur Respir J (1998) 1.09

Role of individual and contextual effects in injury mortality: new evidence from small area analysis. Inj Prev (2002) 1.05

Health-related quality of life in young cocaine users and associated factors. Qual Life Res (2008) 1.02

Psychiatric comorbidity in young heroin users. Drug Alcohol Depend (2006) 0.98

Mortality due to acute adverse drug reactions: opiates and cocaine in Barcelona, 1989-93. Addiction (1996) 0.98

Depression among regular heroin users: the influence of gender. Addict Behav (2011) 0.97

Survival of a large cohort of HIV-infected tuberculosis patients in the era of highly active antiretroviral treatment. Int J Tuberc Lung Dis (2011) 0.96

A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study. J Viral Hepat (2008) 0.95

Predictors of tuberculosis transmission in prisons: an analysis using conventional and molecular methods. AIDS (2000) 0.95

Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C. J Hepatol (2013) 0.95

B-lymphocytes and co-stimulatory molecules in Mycobacterium tuberculosis infection. Int J Tuberc Lung Dis (2004) 0.94

A small area analysis estimating the prevalence of addiction to opioids in Barcelona, 1993. J Epidemiol Community Health (1999) 0.93

[Discrepancies in the number of deaths from an acute reaction to psychoactive substances recorded in Spain]. Gac Sanit (1999) 0.93

Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison. Int J Tuberc Lung Dis (2000) 0.92

Molecular and conventional epidemiology of tuberculosis in an inner city district. Int J Tuberc Lung Dis (2001) 0.91

[An evaluation of the epidemiological surveillance system for infectious diseases in the Barcelona Olympic Games of 1992]. Gac Sanit (1995) 0.91

Tuberculosis transmission patterns among Spanish-born and foreign-born populations in the city of Barcelona. Clin Microbiol Infect (2009) 0.91

Effectiveness of tuberculosis control programmes in prisons, Barcelona 1987-2000. Int J Tuberc Lung Dis (2002) 0.88

Factors predicting non-completion of tuberculosis treatment among HIV-infected patients in Barcelona (1987-1996). Int J Tuberc Lung Dis (2000) 0.87

Predictive factors of HIV-infection in injecting drug users upon incarceration. Eur J Epidemiol (1998) 0.87

[Influence of social inequality, social unrest and extreme poverty on tuberculosis morbidity in the City of Barcelona]. Rev Esp Salud Publica (2002) 0.85

Substance use among road traffic casualties admitted to emergency departments. Inj Prev (2009) 0.84

Prevalence of latent tuberculosis infection in inmates recently incarcerated in a men's prison in Barcelona. Int J Tuberc Lung Dis (2012) 0.84

[Mortality trends in the young people of the city of Barcelona, 1983-1993]. Med Clin (Barc) (1997) 0.84

Evaluation of a social health intervention among homeless tuberculosis patients. Tuber Lung Dis (1996) 0.83

Increased risk of tuberculosis transmission in families with microepidemics. Eur Respir J (1997) 0.83

Smoking in tuberculosis patients increases the risk of infection in their contacts. Int J Tuberc Lung Dis (2013) 0.83

CD4+ lymphocytes and tuberculin skin test as survival predictors in pulmonary tuberculosis HIV-infected patients. Int J Epidemiol (1998) 0.82

An outbreak of Legionnaires' disease in an inner city district: importance of the first 24 hours in the investigation. Int J Tuberc Lung Dis (2002) 0.82

[Differential characteristics of AIDS in foreign immigrants]. Gac Sanit (2000) 0.80

Predictors of the survival of AIDS cases in Barcelona, Spain. AIDS (1989) 0.80

Sore throat, antibiotics, and progression to meningococcal disease. Lancet (1995) 0.79

[Malaria. Analysis of 149 cases (1981-1987)]. Enferm Infecc Microbiol Clin (1990) 0.79

Eliminating congenital rubella syndrome in Spain: does massive immigration have any influence? Eur J Public Health (2008) 0.78

[A community outbreak of Legionnaires' disease in Barcelona: epidemiologic and environmental study]. Med Clin (Barc) (1989) 0.78

[The decline of tuberculosis infection in schoolchildren of Barcelona]. Med Clin (Barc) (1988) 0.78

[Reporting new HIV cases in Catalonia, Spain: is technical consensus feasible?]. Gac Sanit (2003) 0.78

The evolution of tuberculosis infection among schoolchildren in Barcelona and the HIV epidemic. Tuber Lung Dis (1994) 0.78

[Hydatidosis in Catalonia. Study of patients younger than 20 years of age (1977-1985)]. Med Clin (Barc) (1989) 0.78

Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis. Int J Tuberc Lung Dis (1998) 0.78

[Methadone maintenance programs with supplementary services: a cost-effectiveness study]. Gac Sanit (2003) 0.78

Quality of tuberculosis guidelines: urgent need for improvement. Int J Tuberc Lung Dis (2010) 0.77

[Tuberculosis trends in Barcelona (1987-1995). Impact of the human immunodeficiency virus and control measures]. Med Clin (Barc) (1998) 0.77

Outbreak of lymphogranuloma venereum among men who have sex with men in Barcelona 2007/08--an opportunity to debate sexual health at the EuroGames 2008. Euro Surveill (2008) 0.77

[Coping with the toll of heroin: 10 years of the Barcelona Action Plan on Drugs, Spain]. Gac Sanit (2000) 0.77

[Delay in diagnosis of HIV infection]. Rev Esp Sanid Penit (2012) 0.76

Two simultaneous botulism outbreaks in Barcelona: Clostridium baratii and Clostridium botulinum. Epidemiol Infect (2012) 0.76

Detection of unsuspected cases of nosocomial transmission of tuberculosis by use of a molecular typing method. Clin Infect Dis (2001) 0.76

Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders. Qual Life Res (2015) 0.76

[HIV infection and AIDS in Spanish prisons: an impossible challenge for public health?]. Gac Sanit (1997) 0.75

[Course of human immunodeficiency virus infection and programs with adequate retention capacity in the control of acquired immunodeficiency syndrome and tuberculosis in parenteral drug addicts]. Med Clin (Barc) (1992) 0.75

[Tuberculosis, recent transmission and prisons]. Med Clin (Barc) (2000) 0.75

[Consensus document on the prevention and control of tuberculosis in Spain]. Med Clin (Barc) (2000) 0.75

Prevalence of problematic cocaine consumption in a city of southern Europe, using capture-recapture with a single list. J Urban Health (2004) 0.75

Tuberculosis infection and disease among schoolchildren: the influence of the HIV epidemic and of other factors. J Epidemiol Community Health (1999) 0.75

Mycobacterium tuberculosis transmission and HIV status. Lancet (2000) 0.75

[Coverage of preventive educational programs in secondary schools]. Gac Sanit (2001) 0.75

[How much tuberculosis do we want?]. Rev Esp Salud Publica (2001) 0.75

[The impact of AIDS on the increase in premature mortality in the city of Barcelona]. Med Clin (Barc) (1993) 0.75

Towards legionnaires' disease control: epidemiological or environmental surveillance? J Epidemiol Community Health (2003) 0.75

[Is the human immunodeficiency virus infection among intravenous drug addicts dropping in Barcelona?]. Med Clin (Barc) (1995) 0.75

[On the heroin epidemic, its impact, its context, and health policy]. Med Clin (Barc) (1999) 0.75

[Health promotion in relation to HIV in the prison environment]. Gac Sanit (1997) 0.75

[Primary tubercular infection in school children]. Med Clin (Barc) (1989) 0.75

[Evolution of the prevalence of Mycobacterium tuberculosis infection in a penitentiary population on admission to prison from 1991 to 1996]. Med Clin (Barc) (1998) 0.75

[Tuberculosis in Barcelona. Analysis of 899 cases reported in 1986]. Med Clin (Barc) (1988) 0.75

[Evaluation of the tuberculosis control programs of the autonomous regions of Spain]. Med Clin (Barc) (1999) 0.75

Vaccination against HBV in France. Lancet (1999) 0.75

[Tuberculosis morbidity in Spain]. Med Clin (Barc) (1987) 0.75

[Epidemic outbreak of hepatitis A related to a day care center]. Gastroenterol Hepatol (1998) 0.75

[Epidemiologic study of human hydatidosis in Catalunya (1977-1981) (II)]. Med Clin (Barc) (1986) 0.75

Monitoring treatment demand for drug abuse in Spain: perspective over a decade. Eur Addict Res (1999) 0.75

Pulmonary tuberculosis in HIV-infected patients as criterion for AIDS in Europe. Lancet (1993) 0.75

The influence of intravenous drug use and HIV infection in the transmission of tuberculosis. AIDS (1996) 0.75

[Difficulties in carrying out the treatment as seen by the tuberculous patient]. Aten Primaria (1992) 0.75

[Evidence-based tuberculosis control: a public health approach]. Med Clin (Barc) (1999) 0.75

[It is possible to eradicate human hydatidosis from Spain?]. Med Clin (Barc) (1987) 0.75